首页/数据集/Novel RORg inverse agonists do not modulate androgen receptor activity in prostate cancer

Novel RORg inverse agonists do not modulate androgen receptor activity in prostate cancer

ChEBI2019-12-31 更新2026-07-12 收录

前列腺癌靶向治疗

核受体药物机制

数据链接：

https://www.ebi.ac.uk/biostudies/ArrayExpress/studies/E-MTAB-7294 数据链接链接失效反馈

官方服务：

资源简介：

Novel RORg inverse agonists do not modulate androgen receptor activity in prostate cancer

应用场景：

创建时间：

2019-12-31

前列腺癌靶向治疗

放射性药物研发

Prostate-specific membrane antigen (PSMA) is a promising target for the diagnosis and radionuclide therapy of prostate cancer. This study reports conversion of a previously reported 68Ga-imaging agent

NIAID Data Ecosystem110

Integrated omics profiling reveals FOXA1 and Ku70/Ku80 as the direct target of ivermectin for prostate carcinogenic inhibition

前列腺癌靶向治疗

药物机制研究

Here, we show that ivermectin suppress prostate cancer progression by inhibiting AR signaling pathway and attenuate cellular DNA damage repair capacity. We applied an integrated omics profiling includ

NIAID Data Ecosystem60

The translational landscape of mTOR signaling steers cancer initiation and metastasis

疾病翻译调控

前列腺癌靶向治疗

The mammalian target of rapamycin (mTOR) kinase is a master regulator of protein synthesis that couples nutrient sensing to cell growth and cancer. However, the downstream translationally regulated no

NIAID Data Ecosystem30

Discovery of Potent DYRK2 Inhibitors with High Selectivity, Great Solubility, and Excellent Safety Properties for the Treatment of Prostate Cancer

前列腺癌靶向治疗

DYRK2

Prostate cancer (PCa) is a common male cancer with high incidence and mortality, and hormonal therapy as the major treatment for PCa patients is troubled by the inevitable resistance that makes us ide

NIAID Data Ecosystem80

Treatment with the WNT5A-mimicking Peptide Foxy-5 Effectively Reduces the Metastatic Spread of WNT5A-low Prostate Cancer Cells in an Orthotopic Mouse Model

前列腺癌靶向治疗

癌症转移抑制模型

The raw data behind the figures of the published paper

Figshare2017-08-28 更新40